Home / abpnews home / Indanlatestnews / Bharat Biotech Receives DCGI's Approval For Phase 2/3 Clinical Trial Of Covaxin In Children Aged 2 To 18 Yrs

Bharat Biotech Receives DCGI's Approval For Phase 2/3 Clinical Trial Of Covaxin In Children Aged 2 To 18 Yrs

مايو 12, 2021 abpnews home, Indanlatestnews

DCGI Approves Phase 2/3 Clinical Trial Of Covaxin In Age Group Of 2 To 18 Yrs

ليست هناك تعليقات

الاشتراك في: تعليقات الرسالة ( Atom )